Caracterización clínico-epidemiológica de la endocarditis infeccio-sa  según tratamiento aplicado

Mariam González Gorrín; Daniel Silva Brito; Carlos Ramos Emperador

Authors

Mariam González Gorrín Servicio de Cardiología, Hospital Clínico Quirúrgico Herrmanos Ameijeiras. La Habana, Cuba. https://orcid.org/0000-0003-4912-2255
Daniel Silva Brito
Carlos Ramos Emperador https://orcid.org/0000-0003-2989-1284

Abstract

Introduction: Infective endocarditis, although infrequent, constitutes a highly serious and potentially lethal disease.

Objective: The aim of this study was to describe the clinico-epidemiological behavior of patients diagnosed with infective endocarditis, focusing on the received treatment.

Method: We conducted a descriptive, cross-sectional study with patients diagnosed with infective endocarditis at the Hospital Hermanos Ameijeiras in Havana, Cuba, during the period from January 2006 to December 2019. The sample included 199 patients.

Results: A male predominance (74.9%) was observed, with the most affected age group being between 50 and 69 years (43.7%). Among predisposing factors, immunocompromised patients (25.8%) and those with acquired valvular heart disease (24.7%) showed the highest prevalence in the group treated solely with medical approaches. Conversely, in the group receiving medical-surgical treatment, patients with valve prostheses (27.4%) and cardiac implantable electronic devices (21.7%) were more prominent. Left native valve endocarditis was the most common (62.3%), with staphylococci as the predominant causative agent (27.1%). Cardiac and renal complications were predominant in both treatment groups. Survival during hospitalization reached 79.4%, maintaining similarity in both treatment groups.

Conclusions: The clinical-epidemiological profile was similar in both treatment modalities, emphasizing the predominance of male patients, older age, and the frequent presence of staphylococci as the causative agent. Medical-surgical intervention was primarily directed towards patients with intracardiac electronic devices and in situations with associated complications. Mortality was directly associated with the incidence of complications, irrespective of the administered treatment.

Downloads

Download data is not yet available.

Author Biography

Mariam González Gorrín, Servicio de Cardiología, Hospital Clínico Quirúrgico Herrmanos Ameijeiras. La Habana, Cuba.

Especialista de Primer Grado en Cardiología. Profesor Auxiliar.

References

1. García-Arribas D, Olmos C, Vivas Balcones D, Vilacosta I. Endocarditis infecciosa. Medicine. 2017;12(40):2380-95. DOI: https://doi.org/10.1016/j.med.2017.09.004

2. Yang E, Frazee BW. Infective Endocarditis. Emerg Med Clin North Am. 2018;36(4):645-63. DOI: https://doi.org/10.1016/j.emc.2018.06.002

3. Flores P, González N, Betancourt P, Berho J, Astudillo C, García C, et al. Endocarditis Infecciosa: caracterización clínica de la enfermedad. Revisión de casos de los últimos 5 años. Rev Chil Cardiol. 2017;36(1):34-40. DOI: http://dx.doi.org/10.4067/S0718-85602017000100004

4. Mestres CA, Paré JC, Miró JM; Working Group on Infective Endocarditis of the Hospital Clínic de Barcelona. Organización y funcionamiento de un grupo multidisciplinario de diagnóstico y tratamiento de la endocarditis infecciosa: perspectiva de 30 años (1985–2014). Rev Esp Cardiol. 2015;68(5):363-8. DOI: https://doi.org/10.1016/j.recesp.2014.10.007

5. Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070-6. DOI: https://doi.org/10.1016/j.jacc.2015.03.518

6. Fernandez-Gerlinger MP, Mainardi JL. Endocarditis infecciosa: del diagnóstico al tratamiento. EMC - Tratado de Medicina. 2016;20(4):1-7. DOI: http://dx.doi.org/10.1016/S1636-5410(16)80656-X

7. Thomas T, Patterson KB, Patterson C. Infective Endocarditis. En: Stouffer GA, Runge MS, Patterson C, Rossi JS, eds. Netter's Cardiology. 3ª ed. Barcelona: Elsevier; 2019. pp. 341-7.

8. Habib G, Salaun E, Hubert S. Infective Endocarditis: A Deadly Disease if Diagnosed Too Late. J Am Soc Echocardiogr. 2016;29(4):323-4. DOI: https://doi.org/10.1016/j.echo.2016.02.010

9. García-Granja PE, López J, Vilacosta I, Sarriá C, Domínguez F, Ladrón R, et al. Modelo predictivo de mortalidad hospitalaria en endocarditis infecciosa izquierda. Rev Esp Cardiol. 2020;73(11):902-9. DOI: https://doi.org/10.1016/j.recesp.2020.04.010

10. Narvaez AF, Granda A, Sierra J, Adrio B, Reija L. Endocarditis aórtica y pulmonar complicada con ictus hemorrágico: ¿cuál es el tiempo quirúrgico ideal? Cir Cardiov. 2016;23(5):255-8. DOI: https://doi.org/10.1016/j.circv.2015.11.003

11. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa. Rev Esp Cardiol. 2016;69(1):69.e1-e49. DOI: https://doi.org/10.1016/j.recesp.2015.11.015

12. Casabé JH, Varini S, Barisani JL, Guerchi JP, Luna MA, Vay C, et al. Consenso de endocarditis Infecciosa / Versión resuminda. Rev Argent Cardiol. 2016;84(5):507-14. Enlace: http://www.old2.sac.org.ar/wp-content/uploads/2016/12/v84n5a19-es-1.pdf

13. Bin Abdulhak AA, Tleyjeh IM. Indications of Surgery in Infective Endocarditis. Curr Infect Dis Rep [Internet]. 2017 [citado 5 May 2022];19(3):10. Disponible en: https://doi.org/10.1007/s11908-017-0569-6

14. Soud M, Moussa Pacha H, Alraies MC. How soon should patients with infective endocarditis be referred for valve surgery? Cleve Clin J Med. 2018;85(5):362-4. DOI: https://doi.org/10.3949/ccjm.85a.17052

15. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466-73. DOI: https://doi.org/10.1056/nejmoa1112843

16. Cediel GE, Santos S, Guillén M, de Castro R, Sanz E, Bardají A. Impacto de la cirugía cardiaca sobre el pronóstico de los pacientes con endocarditis infecciosa en nuestro medio. Rev Esp Cardiol. 2015;68(Supl. 1):974. [Resumen] Enlace: https://www.revespcardiol.org/es-congresos-sec-2015-el-congreso-19-sesion-cardiologia-clinica-1640-impacto-cirugia-cardiaca-sobre-el-18790-pdf

17. Vidal L, Sáez JI, Riera M, Fernández R, Enríquez F, Padrol D, et al. Cirugía de la endocarditis infecciosa valvular aguda. Resultados y seguimiento a 10 años. Rev Esp Cardiol. 2013;66(Supl. 1):924. [Resumen]. Enlace: https://www.revespcardiol.org/es-congresos-sec-2013-el-congreso-5-sesion-enfermedad-valvular-aorta-633-cirugia-endocarditis-infecciosa-valvular-aguda--6026-pdf

18. Mack MJ, Lancellotti P. Early Surgery in Infective Endocarditis: Can it Be Too Early? J Am Coll Cardiol. 2020;76(1):41-2. DOI: https://doi.org/10.1016/j.jacc.2020.05.049

19. Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg. 2019;8(6):630-44. DOI: https://doi.org/10.21037/acs.2019.10.05

20. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159-e1195. DOI: https://doi.org/10.1161/cir.0000000000000503

21. Olmos C, Vilacosta I, López J, Sarriá C, Ferrera C, San Román JA. Actualización en endocarditis protésica. Cir Cardiov. 2017;24(1):33-40. DOI: https://doi.org/10.1016/j.circv.2016.11.001

22. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. DOI: https://doi.org/10.1093/eurheartj/ehv319

23. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440-92. DOI: https://doi.org/10.1161/cir.0000000000000029

24. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs; Pettersson GB, Coselli JS, Hussain ST, Griffin B, Blackstone EH, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-58.e29. DOI: https://doi.org/10.1016/j.jtcvs.2016.09.093

25. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132(15):1435-86. DOI: https://doi.org/10.1161/cir.0000000000000296

26. Cantier M, Mazighi M, Klein I, Desilles JP, Wolff M, Timsit JF, et al. Neurologic Complications of Infective Endocarditis: Recent Findings. Curr Infect Dis Rep [Internet]. 2017 [citado 5 May 2022];19(11):41. Disponible en: https://doi.org/10.1007/s11908-017-0593-6

27. Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131(2):131-40. DOI: https://doi.org/10.1161/circulationaha.114.012461

28. Dawood MY, Cheema FH, Ghoreishi M, Foster NW, Villanueva RM, Salenger R, et al. Contemporary outcomes of operations for tricuspid valve infective endocarditis. Ann Thorac Surg. 2015;99(2):539-46. DOI: https://doi.org/10.1016/j.athoracsur.2014.08.069

29. Witten JC, Hussain ST, Shrestha NK, Gordon SM, Houghtaling PL, Bakaeen FG, et al. Surgical treatment of right-sided infective endocarditis. J Thorac Cardiovasc Surg. 2019;157(4):1418-1427.e14. DOI: https://doi.org/10.1016/j.jtcvs.2018.07.112

30. Iung B, Duval X. Infective endocarditis: Innovations in the management of an old disease. Nat Rev Cardiol. 2019;16(10):623-35. DOI: https://doi.org/10.1038/s41569-019-0215-0

31. Clémenty N, Carion PL, Léotoing L, Lamarsalle L, Wilquin-Bequet F, Brown B, et al. Infections and associated costs following cardiovascular implantable electronic device implantations: A nationwide cohort study. Europace. 2018;20(12):1974-80. DOI: https://doi.org/10.1093/europace/eux387

32. Allende A, Bermúdez GJ, Mirabal R, Quintero YF, López Y, Chaljub E. Caracterización clínico-epidemiológica con enfoque quirúrgico de la endocarditis infecciosa en la región central de Cuba. CorSalud [Internet]. 2020 [citado 9 May 2022];12(2):138-45. Disponible en: https://revcorsalud.sld.cu/index.php/cors/article/view/650/1153

33. Ramos C, González M, López M, Sánchez RJ, Costa T. Mortalidad en pacientes egresados vivos con endocarditis infecciosa. Rev Cuban Cardiol [Internet]. 2019 [citado 9 May 2022];25(4). Disponible en: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/872/pdf

34. Buitrago F, Román M, Rivera N, Ávila F, Tejero M. Profilaxis antibiótica de la endocarditis infecciosa. FMC: Form Méd Contin Aten Prim. 2019;26(6):346-51. Enlace: https://www.fmc.es/es-pdf-S1134207219300969

35. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study. Eur Heart J. 2019;40(39):3222-32. DOI: https://doi.org/10.1093/eurheartj/ehz620

36. Ruch Y, Mazzucotelli JP, Lefebvre F, Martin A, Lefebvre N, Douiri N, et al. Impact of Setting up an "Endocarditis Team" on the Management of Infective Endocarditis. Open Forum Infect Dis [Internet]. 2019 [citado 12 May 2022];6(9):ofz308. Disponible en: https://doi.org/10.1093/ofid/ofz308

37. Ilhão Moreira R, Coutinho Cruz M, Moura Branco L, Galrinho A, Coutinho Miranda L, Fragata J, et al. Infective endocarditis: Surgical management and prognostic predictors. Rev Port Cardiol (Engl Ed). 2018;37(5):387-94. DOI: https://doi.org/10.1016/j.repc.2017.08.007

38. Mackie AS, Liu W, Savu A, Marelli AJ, Kaul P. Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines. Can J Cardiol. 2016;32(8):942-8. DOI: https://doi.org/10.1016/j.cjca.2015.09.021

39. Ren Z, Mo X, Chen H, Peng J. A changing profile of infective endocarditis at a tertiary hospital in China: a retrospective study from 2001 to 2018. BMC Infect Dis [Internet]. 2019 [citado 12 May 2022];19(1):945. Disponible en: https://doi.org/10.1186/s12879-019-4609-8

40. Marques A, Cruz I, Caldeira D, Alegria S, Gomes AC, Broa AL, et al. Risk Factors for In-Hospital Mortality in Infective Endocarditis. Arq Bras Cardiol. 2020;114(1):1-8. DOI: https://doi.org/10.36660/abc.20180194

41. Gálvez-Acebal J, Almendro-Delia M, Ruiz J, de Alarcón A, Martínez-Marcos FJ, Reguera JM, et al. Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: A multicenter cohort study. Mayo Clin Proc. 2014;89(10):1397-405. DOI: https://doi.org/10.1016/j.mayocp.2014.06.021

42. Jia YX, Li Y, Meng X, Xu CL, Zeng W, Jiao YQ, et al. Clinical Analysis of 161 Cases of Surgical Treatment of Infective Endocarditis. Surg Infect (Larchmt). 2019;20(8):637-42. DOI: https://doi.org/10.1089/sur.2019.001

43. Yuan XC, Liu M, Hu J, Zeng X, Zhou AY, Chen L. Diagnosis of infective endocarditis using echocardiography. Medicine (Baltimore) [Internet]. 2019 [citado 12 May 2022];98(38):e17141. Disponible en: http://dx.doi.org/10.1097/MD.0000000000017141

44. Varela L, Vidal L, Fernández-Félix BM, Ventosa G, Navas E, Hidalgo I, et al. Estimación de la mortalidad quirúrgica de la endocarditis infecciosa: comparación de las diferentes escalas específicas de cálculo de riesgo. Cir Cardiov. 2020;27(3):93-9. DOI: https://doi.org/10.1016/j.circv.2020.06.002

45. Giner-Caro JA, Jimeno-Almazán A, Alcaraz-Vidal B, Cobos-Trigueros N, Rojano-Torres R, del Amor-Espín MJ, et al. ¿Operamos todo lo que debemos en endocarditis infecciosa? Resultados de la cirugía en nuestro medio. Cir Cardiov. 2018;25(1):64. DOI: https://doi.org/10.1016/j.circv.2017.12.023

46. Otálora S, Hernández A, Gómez J, Herrero JA, García E. Estudio de una cohorte de pacientes con endocarditis infecciosa en un hospital universitario de tercer nivel. Cir Cardiov. 2018;25(1):53. DOI: https://doi.org/10.1016/j.circv.2017.12.004

47. Mahmoud MO, Dokhan AL, Allama AM, Mostafa MO. Surgical management of infective endocarditis: risk factors affecting early outcome. Menoufia Med J. 2019;32(2):610-7. DOI: https://doi.org/10.4103/mmj.mmj_121_18

48. Fernández-Cisneros A, Sandoval E, Hernández-Meneses M, Pereda D, Ambrosioni J, Castellá M, et al. Cirugía de la endocarditis infecciosa valvular izquierda aguda. Resultados en el hospital clínic de Barcelona. Cir Cardiov. 2019;26(2):141. DOI: https://doi.org/10.1016/j.circv.2019.01.068

49. Peric? JM, Llopis J, González-Ramallo V, Goenaga MÁ, Muñoz P, García-Leoni ME, et al. Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES Cohort. Clin Infect Dis. 2019;69(10):1690-1700. DOI: https://doi.org/10.1093/cid/ciz030

50. Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2015;33(9):625.e1-e23. DOI: https://doi.org/10.1016/j.eimc.2015.03.015

51. Yokoyama J, Yoshioka D, Toda K, Matsuura R, Suzuki K, Samura T, et al. Surgery-first treatment improves clinical results in infective endocarditis complicated with disseminated intravascular coagulation. Eur J Cardiothorac Surg. 2019;56(4):785-92. DOI: https://doi.org/10.1093/ejcts/ezz068

52. Calvo Cano A, Rodríguez-Vidigal FF, Vera Tomé A, Nogales-Muñoz N, Muñoz-Sanz A. Perfil clínico y pronóstico de las endocarditis con hemocultivos negativos en un hospital terciario. Cir Cardiov. 2019;26(2):132. DOI: https://doi.org/10.1016/j.circv.2019.01.049

53. Noureddine-López M, de la Torre-Lima J, Ruiz-Morales J, Gálvez-Acebal J, Hidalgo-Tenorio C, de Alarcón González CA; por el Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Endocarditis infecciosas izquierdas, cambios con el nuevo milenio. Med Clin (Barc). 2019;153(2):63-6. DOI: https://doi.org/10.1016/j.medcli.2018.04.018

54. Van Vlasselaer A, Rasmussen M, Nilsson J, Olaison L, Ragnarsson S. Native aortic versus mitral valve infective endocarditis: a nationwide registry study. Open Heart [Internet]. 2019 [citado 14 May 2022];6(1):e000926. Disponible en: https://doi.org/10.1136/openhrt-2018-000926

55. Selton-Suty C, Delahaye F, Tattevin P, Federspiel C, Le Moing V, Chirouze C, et al. Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis. PLoS One [Internet]. 2016 [citado 14 May 2022];11(7):e0158522. Disponible en: https://doi.org/10.1371/journal.pone.0158522

56. Vallejo Camazón N, Cediel G, Núñez Aragón R, Mateu L, Llibre C, Sopena N, et al. Mortalidad a corto y largo plazo de pacientes con indicación quirúrgica no intervenidos en el curso de la endocarditis infecciosa izquierda. Rev Esp Cardiol. 2020;73(9):734-40. DOI: https://doi.org/10.1016/j.recesp.2019.09.023